Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ORCHIECTOMY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 412 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Klotz, L
      Combined androgen blockade in prostate cancer: meta-analyses and associated issues

      BJU INTERNATIONAL
    2. Poulopoulos, AK; Antoniades, K; Kiziridou, A; Antoniades, V
      Testicular embryonal carcinoma metastatic to the labial mucosa of the upper lip

      ORAL ONCOLOGY
    3. Schasfoort, EMC; van de Beek, C; Newling, DWW
      Safety and efficacy of a nonsteroidal anti-androgen, based on results of apost marketing surveillance of nilutamide

      PROSTATE CANCER AND PROSTATIC DISEASES
    4. Sternberg, CN
      Systemic treatment and new developments in advanced prostate cancer

      EUROPEAN JOURNAL OF CANCER
    5. Potosky, AL; Knopf, K; Clegg, LX; Albertsen, PC; Stanford, JL; Hamilton, AS; Gilliland, FD; Eley, JW; Stephenson, RA; Hoffman, RM
      Quality-of-life outcomes after primary androgen deprivation therapy: Results from the prostate cancer outcomes study

      JOURNAL OF CLINICAL ONCOLOGY
    6. Huuskonen, J; Arnala, I; Olkkonen, H; Alhava, E
      Alendronate influences bending force of femoral diaphysis after orchidectomy in rats

      ANNALES CHIRURGIAE ET GYNAECOLOGIAE
    7. Ruutu, M; Mikkola, A; Petas, A
      Treatment of prostate cancer - Any news?

      ANNALES CHIRURGIAE ET GYNAECOLOGIAE
    8. Iversen, P; Abrahamsson, PA; Mulders, PFA
      Advanced prostate cancer

      EUROPEAN UROLOGY
    9. Abrahamsson, PA
      Treatment of locally advanced prostate cancer - A new role for antiandrogen monotherapy?

      EUROPEAN UROLOGY
    10. Saikawa, S; Kanamaru, H; Noriki, S; Matsukawa, S; Okada, K
      The effects of organ resection on rat urinary bladder carcinogenesis

      UROLOGICAL RESEARCH
    11. Collette, L; Studer, UE; Schroder, FH; Denis, LJ; Sylvester, RJ
      Why phase III trials of maximal androgen blockade versus castration in M-1prostate cancer rarely show statistically significant differences

      PROSTATE
    12. Libouban, H; Moreau, MF; Legrand, E; Basle, MF; Audran, M; Chappard, D
      Comparison insight dual X-ray absorptiometry (DXA), histomorphometry, ash weight, and morphometric indices for bone evaluation in an animal model (the orchidectomized rat) of male osteoporosis

      CALCIFIED TISSUE INTERNATIONAL
    13. Jordan, GH
      Laparoscopic management of the undescended testicle

      UROLOGIC CLINICS OF NORTH AMERICA
    14. Schellhammer, PF
      Luteinizing hormone-releasing hormone monotherapy: A viable option for treatment of prostate cancer?

      UROLOGY
    15. Daniell, HW
      Osteoporosis due to androgen deprivation therapy in men with prostate cancer

      UROLOGY
    16. Peehl, DM; Seto, E; Feldman, D
      Rationale for combination ketoconazole/vitamin D treatment of prostate cancer

      UROLOGY
    17. Zagars, GK; Pollack, A; von Eschenbach, AC
      Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer

      UROLOGY
    18. Schmitt, B; Wilt, TJ; Schellhammer, PF; DeMasi, V; Sartor, O; Crawford, ED; Bennett, CL
      Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: A systematic review

      UROLOGY
    19. Dieckmann, KP; Classen, J; Souchon, R; Loy, V
      Management of testicular intraepithelial neoplasia (TIN) - a review on thefoundation of evidence based medicine (EBM)

      WIENER KLINISCHE WOCHENSCHRIFT
    20. Dundar, M; Erol, H; Kocak, I; Kacar, F
      Liposarcoma of the spermatic cord

      UROLOGIA INTERNATIONALIS
    21. Sarica, K; Bakir, K; Erbagci, A; Yagci, F; Uysal, O; Ucak, R
      Unilateral testicular torsion: Evaluation of bcl-2, p-53 and PCNA expression in contralateral testes

      UROLOGIA INTERNATIONALIS
    22. Bondy, SJ; Iscoe, NA; Rothwell, DM; Gort, EH; Fleshner, NE; Paszat, LF; Browman, GP
      Trends in hormonal management of prostate cancer: A population-based studyin Ontario

      MEDICAL CARE
    23. Heidenreich, A; Weissbach, L; Holtl, W; Albers, P; Kliesch, S; Kohrmann, KU; Dieckmann, KP
      Organ sparing surgery for malignant germ cell tumor of the testis

      JOURNAL OF UROLOGY
    24. Roeleveld, TA; Horenblas, S; Meinhardt, W; van de Vijver, M; Kooi, M; Huinink, WWTB
      Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients

      JOURNAL OF UROLOGY
    25. Spetz, AC; Pettersson, B; Varenhorst, E; Theodorsson, E; Thorell, LH; Hammar, M
      Momentary increase in plasma calcitonin gene-related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate

      JOURNAL OF UROLOGY
    26. Spetz, AC; Hammar, M; Lindberg, B; Spangberg, A; Varenhorst, E
      Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate

      JOURNAL OF UROLOGY
    27. Kizer, WS; Dykes, TE; Brent, EL; Chatham, JR; Schwartz, BF
      Paratesticular spindle cell rhabdomyosarcoma in an adult

      JOURNAL OF UROLOGY
    28. Pitts, WR
      Re: Medical versus surgical androgen suppression therapy for prostate cancer: A 10-year longitudinal cost study - A. J. Mariani, M. Glover and S. Arita - J Urol, 165: 104-107, 2001

      JOURNAL OF UROLOGY
    29. Smith, MR; McGovern, FJ
      Gonadotropin-releasing hormone agonist failure in a man with prostate cancer

      JOURNAL OF UROLOGY
    30. Ganjoo, KN; Foster, RS; Michael, H; Donohue, JP; Einhorn, LH
      Germ cell tumor associated primitive neuroectodermal tumors

      JOURNAL OF UROLOGY
    31. Straub, B; Muller, M; Schrader, M; Heicappell, R; Miller, K
      Osteoporosis and mild metabolic acidosis in the rat after orchiectomy and their prevention: Should prophylactic therapy be administered to patients with androgen deprivation?

      JOURNAL OF UROLOGY
    32. Mariani, AJ; Glover, M; Arita, S
      Medical versus surgical androgen suppression therapy for prostate cancer: A 10-year longitudinal cost study

      JOURNAL OF UROLOGY
    33. Danikas, D; Sachs, R; Dressner, RM; Arvanitis, ML
      Testicular metastasis from Ileal carcinoid - Report of a case

      DISEASES OF THE COLON & RECTUM
    34. Diamond, TH; Winters, J; Smith, A; De Souza, P; Kersley, JH; Lynch, WJ; Bryant, C
      The anti osteo porotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade - A double blind, randomized, placebo-controlled crossover study

      CANCER
    35. Sebo, TJ; Cheville, JC; Riehle, DL; Lohse, CM; Pankratz, VS; Myers, RP; Blute, ML; Zincke, H
      Predicting prostate carcinoma volume and stage at radical prostatectomy byassessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen - A report of 454 cases

      CANCER
    36. Daniell, HW; Clark, JC; Pereira, SE; Niazi, ZA; Ferguson, DW; Dunn, SR; Figueroa, ML; Stratte, PT
      Hypogonadism following prostate-bed radiation therapy for prostate carcinoma

      CANCER
    37. Yao, W; Jee, WSS; Chen, J; Tam, CS; Setterberg, RB; Frost, HM
      Erect bipedal stance exercise partially prevents orchidectomy-induced boneloss in the lumbar vertebrae of rats

      BONE
    38. Denis, LJ; Griffiths, K
      Endocrine treatment in prostate cancer

      SEMINARS IN SURGICAL ONCOLOGY
    39. Hendry, WF; Norman, A; Nicholls, J; Dearnaley, DP; Peckham, MJ; Horwich, A
      Abdominal relapse in stage 1 nonseminomatous germ cell tumours of the testis managed by surveillance or with adjuvant chemotherapy

      BJU INTERNATIONAL
    40. Newling, DWW
      Maximum androgen blockade: a case study report

      PROSTATE CANCER AND PROSTATIC DISEASES
    41. Newling, DWW
      Tailoring of hormonal therapy in prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    42. Nash, AF; Melezinek, I
      The role of prostate specific antigen measurement in the detection and management of prostate cancer

      ENDOCRINE-RELATED CANCER
    43. Kaisary, AV
      Patient-clinician choice in palliation of metastatic prostate cancer

      DRUGS & AGING
    44. Moul, JW
      Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy

      MOLECULAR UROLOGY
    45. White, RD
      Present and future management of prostate cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    46. Sousa, A; Gayoso, R; Lopez-Bellido, D; Reboredo, J; Perez-Valcarcel, J; Fuentes, M
      Laparoscopic assessment and orchidectomy for the adult undescended testis

      SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES
    47. Mathur, PP; Marshall, A; Cheng, CY
      Protein profiles in various epididymal segments of normal and castrated rats

      ASIAN JOURNAL OF ANDROLOGY
    48. Gao, CQ; Van den Saffele, J; Giri, M; Kaufman, JM
      Guinea-pig gonadotropin-releasing hormone: Immunoreactivity and biologicalactivity

      JOURNAL OF NEUROENDOCRINOLOGY
    49. Dreicer, R
      The evolving role of hormone therapy in advanced prostate cancer

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    50. Erben, RG; Eberle, J; Stahr, K; Goldberg, M
      Androgen deficiency induces high turnover osteopenia in aged male rats: A sequential histomorphometric study

      JOURNAL OF BONE AND MINERAL RESEARCH
    51. Kasimis, B; Wilding, G; Kreis, W; Feuerman, M; Chang, V; Hwang, S; Steafather, H; Cogswell, J; Rae, C; Blumenfrucht, M
      Survival of patients who had salvage castration after failure on bicalutamide monotherapy for stage (D-2) prostate cancer

      CANCER INVESTIGATION
    52. Rabbani, F; Sheinfeld, J; Farivar-Mohseni, H; Leon, A; Rentzepis, MJ; Reuter, VE; Herr, HW; McCaffrey, JA; Motzer, RJ; Bajorin, DF; Bosl, GJ
      Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: Pattern and prognostic factors for relapse

      JOURNAL OF CLINICAL ONCOLOGY
    53. Gheiler, EL; Tiguert, R
      Current concepts in androgen deprivation therapy - is there a "best" endocrine treatment?

      WORLD JOURNAL OF UROLOGY
    54. De Palma, A; Vicari, E; Palermo, I; D'Agata, R; Calogero, AE
      Effects of cancer and anti-neoplastic treatment on the human testicular function

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    55. Egawa, S; Takashima, R; Matsumoto, K; Mizoguchi, H; Kuwao, S; Baba, S
      A pilot study of intermittent androgen ablation in advanced prostate cancer in Japanese men

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    56. Tyrrell, CJ; Altwein, JE; Klippel, F; Jurincic-Winkler, C; Varenhorst, E; Lunglmayr, G; Boccardo, F; Holdaway, IM; Haefliger, JM; Jordaan, JP
      Comparison of an LH-RH analogue (Goeserelin Acetate, 'Zoladex') with combined androgen blockade in advanced prostate cancer: Final survival results of an international multicentre randomized-trial

      EUROPEAN UROLOGY
    57. Waters, DJ; Shen, SR; Glickman, LT
      Life expectancy, antagonistic pleiotropy, and the testis of dogs and men

      PROSTATE
    58. Van Cangh, PJ; Gala, JL; Tombal, B
      Immediate vs. delayed androgen deprivation for prostate cancer

      PROSTATE
    59. Stege, R
      Potential side-effects of endocrine treatment of long duration in prostatecancer

      PROSTATE
    60. Turner, RT; Evans, GL; Dobnig, H
      The high-affinity estrogen receptor antagonist ICI 182,780 has no effect on bone growth in young male rats

      CALCIFIED TISSUE INTERNATIONAL
    61. Dalesio, O; van Tinteren, H; Clarke, M; Peto, R; Schroder, FH; Dechering, I; Evans, V; Godwin, J; Blumenstein, BA; Crawford, ED; Denis, L; Hall, R; Hill, C; Iversen, P; Shipley, WU; Soloway, M; Sylvester, R
      Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

      LANCET
    62. Oefelein, MG; Feng, A; Scolieri, MJ; Ricchiutti, D; Resnick, MI
      Reassessment of the definition of castrate levels of testosterone: Implications for clinical decision making

      UROLOGY
    63. McLeod, DG; Iversen, P
      Gynecomastia in patients with prostate cancer: A review of treatment options

      UROLOGY
    64. Sperling, HN; Lummen, G; Schmidt, C; Rubben, H
      Cryptorchidism: Fowler-Stephens procedure or autotransplantation - A new experimental model

      UROLOGY
    65. Aki, FT; Bilen, CY; Tekin, MI; Ozen, H
      Is scrotal violation per se a risk factor for local relapse and metastasesin stage I nonseminomatous testicular cancer?

      UROLOGY
    66. Hedlund, PO; Henriksson, P
      Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: Effects on overall survival and cardiovascular mortality

      UROLOGY
    67. Crawford, ED
      Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: Effects on overall survival and cardiovascular mortality - Editorial comment

      UROLOGY
    68. Sarosdy, MF; Schellhammer, PF; Johnson, R; Carroll, K; Kolvenbag, GJCM
      Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy?

      UROLOGY
    69. Iversen, P; Tyrrell, CJ; Kaisary, AV; Anderson, JB; Van Poppel, H; Tammela, TLJ; Chamberlain, M; Carroll, K; Melezinek, I
      Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup

      JOURNAL OF UROLOGY
    70. Oefelein, MG; Cornum, R
      Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: The case for monitoring serum testosterone and a treatment decision algorithm

      JOURNAL OF UROLOGY
    71. Laufer, M; Denmeade, SR; Sinibaldi, VJ; Carducci, MA; Eisenberger, MA
      Complete androgen blockade for prostate cancer: What went wrong?

      JOURNAL OF UROLOGY
    72. Hermans, BP; Sweeney, CJ; Foster, RS; Einhorn, LE; Donohue, JP
      Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection

      JOURNAL OF UROLOGY
    73. Studer, UE; Burkhard, FC; Sonntag, RW
      Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage I nonseminomatous germ cell tumor

      JOURNAL OF UROLOGY
    74. Daniell, HW; Dunn, SR; Ferguson, DW; Lomas, G; Niazi, Z; Stratte, PT
      Progressive osteoporosis during androgen deprivation therapy for prostate cancer

      JOURNAL OF UROLOGY
    75. Gill, IS; Ross, JH; Sung, GT; Kay, R
      Needlescopic surgery for cryptorchidism: The initial series

      JOURNAL OF PEDIATRIC SURGERY
    76. Magoha, GAO
      Management and survival in advanced prostate cancer in Nairobi

      EAST AFRICAN MEDICAL JOURNAL
    77. Atchley, JTM; Dewbury, KC
      Ultrasound appearances of testicular epidermoid cysts

      CLINICAL RADIOLOGY
    78. Schroder, FH; Collette, L; de Reijke, TM; Whelan, P
      Prostate cancer treated by anti-androgens: is sexual function preserved?

      BRITISH JOURNAL OF CANCER
    79. Seidenfeld, J; Samson, DJ; Hasselblad, V; Aronson, N; Albertsen, PC; Bennett, CL; Wilt, TJ
      Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis

      ANNALS OF INTERNAL MEDICINE
    80. Lawton, AJ; Mead, GM
      Staging and prognostic factors in testicular cancer

      SEMINARS IN SURGICAL ONCOLOGY
    81. Sonneveld, DJA; Koops, HS; Sleijfer, DT; Hoekstra, HJ
      Surgery versus surveillance in stage I non-seminoma testicular cancer

      SEMINARS IN SURGICAL ONCOLOGY
    82. Milosevic, MF; Gospodarowicz, M; Warde, P
      Management of testicular seminoma

      SEMINARS IN SURGICAL ONCOLOGY
    83. Rescorla, FJ
      Pediatric germ cell tumors

      SEMINARS IN SURGICAL ONCOLOGY
    84. Sarosdy, MF; Schellhammer, PF; Soloway, MS; Vogelzang, NJ; Crawford, ED; Presti, J; Chodak, GW; Mitchell, P; Porter, L
      Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer

      BJU INTERNATIONAL
    85. Schroder, FH
      Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects

      BJU INTERNATIONAL
    86. Bennett, CL; Tosteson, TD; Schmitt, B; Weinberg, PD; Ernstoff, MS; Ross, SD
      Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide

      PROSTATE CANCER AND PROSTATIC DISEASES
    87. Mottet, N; Costa, P; Navratil, H
      Intermittent versus continuous hormone deprivation in metastatic prostate cancer: preliminary data from an ongoing European study

      PROSTATE CANCER AND PROSTATIC DISEASES
    88. Ziada, AM; Crawford, ED
      Advanced prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    89. Kawata, T; Fujita, T; Kumegawa, M; Tanne, K
      Congenital osteoclast deficiency in osteopetrotic (op/op) mice is improvedby ovariectomy and orchiectomy

      EXPERIMENTAL ANIMALS
    90. Garnick, MB
      Hormonal therapy in the management of prostate cancer: An historical overview

      MOLECULAR UROLOGY
    91. Kojima, T; Doi, K; Kishi, M; Horiguchi, Y
      Sex-related differences in plasminogen activator and plasminogen activatorinhibiting activities in young and aged rats.

      RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
    92. Stamper, MA; Norton, T; Spodnick, G; Marti, J; Loomis, M
      Hypospadias in a polar bear (Ursus maritimus).

      JOURNAL OF ZOO AND WILDLIFE MEDICINE
    93. Sarosdy, MF
      Which is the optimal antiandrogen for use in combined androgen blockade ofadvanced prostate cancer? The transition from a first- to second-generation antiandrogen

      ANTI-CANCER DRUGS
    94. Wang, WJ; Yeh, YA; Stout, P; Fan, K
      Inverse relationship between Leydig cell density and metastatic potential of prostatic adenocarcinoma

      ANALYTICAL CELLULAR PATHOLOGY
    95. Kanayama, H; Naroda, T; Inoue, Y; Kurokawa, Y; Kagawa, S
      A case of complete testicular feminization: Laparoscopic orchiectomy and analysis of androgen receptor gene mutation

      INTERNATIONAL JOURNAL OF UROLOGY
    96. Boccardo, F; Rubagotti, A; Borichello, M; Battaglia, M; Carmignani, G; Comeri, G; Conti, G; Cruciani, G; Dammino, S; Delliponti, U; Ditonno, P; Ferraris, V; Lilliu, S; Montefiore, F; Portoghese, F; Spano, G
      Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: Results of an Italian Prostate Cancer Project study

      JOURNAL OF CLINICAL ONCOLOGY
    97. Raghavan, D
      Prostate cancer management under scrutiny: The man's meta-analysis is another man's poisson

      JOURNAL OF CLINICAL ONCOLOGY
    98. Mikkola, A; Ruutu, M; Aro, J; Rannikko, S; Salo, J
      The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium

      ANNALES CHIRURGIAE ET GYNAECOLOGIAE
    99. Konrad, D; Schoenle, EJ
      Ten-year follow-up in a boy with Leydig cell tumor after selective surgery

      HORMONE RESEARCH
    100. Zhang, YY; Li, PF; Chen, BL; Li, D
      Flutamide suppressed prostate hypertrophy in rats and mice

      ACTA PHARMACOLOGICA SINICA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 08:06:04